Aimed at advancing its growth strategy in the selfcare space, Perrigo (PRGO +1.4%) has agreed acquire over-the-counter (OTC) rights to GlaxoSmithKline's (GSK -0.6%) heartburn med Prevacid (lansoprazole) for an undisclosed sum.
https://seekingalpha.com/news/3497331-perrigo-buys-otc-rights-glaxos-prevacid
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.